September 9, 2010

Features Index

426 Features
What is Health Economics?

23 Feb 09

Health economics is a growing sub-discipline of economics and studies the allocation of scarce resources in health care.
Editor

Quick Look at Cardiology

20 Feb 09

More than a billion people worldwide are affected by the consequences of high blood pressure and many more suffer without diagnosis, due to a lack of ubiquitous symptoms...
Max Golby

Pfizer acquires Wyeth - What's Next? - Frost & Sullivan Analyst Comment

29 Jan 09

Recent talks are about the recession, economic downturn, credit crunch and so on. However, the pharma giant Pfizer made a remarkable start in 2009.
A. Shabeer Hussain

The Picture Of England's Health

28 Jan 09

We're living longer, but many challenges remain The third national Health Profile of England is published today and demonstrates improvements in critical areas of the nation's health.
Editor

Touch Briefings: eClinical Series - FREE report

07 Jan 09

PharmiWeb is pleased to collaborate with Touch Briefings to provide clinical research professionals FREE access to their latest report - Clinical Trial Management: Enabling Operational Efficiency.
Liam ONeill

The NanoKTN Supports The Significant Investment Of Funds For Collaborative Research In Nanotechnology

06 Jan 09

The Nanotechnology Knowledge Transfer Network (NanoKTN), one of the UK’s primary knowledge-based networks for Micro and Nanotechnologies, has announced its support for one of the largest funding rounds that has been made available to the micro and nanotechnology sector.
Graham Thatcher

Diabetes Alert - One Person Diagnosed Every Three Minutes In The UK

02 Jan 09

One person is diagnosed with diabetes every three minutes* in the UK, according to new figures from Diabetes UK.
Fabienne Jacquet

What is Diabetes

18 Dec 08

According to Diabetes UK, over 2.5 Million people in the UK suffer from diabetes, with half a million of them being unaware they have it.

There are 2 forms of diabetes, and the causes of both types are different, but both result in too much glucose (sugar) in the blood.
Editor

More Help To Get Young People Talking

18 Dec 08

A £12 million action plan to improve services for children and young people with speech, language and communication needs was launched today by Health Secretary Alan Johnson and Children's Secretary Ed Balls.
Editor

New Universal Name Identities an ultra-modern-cyber-age-branding-platform offers exclusive global rights to name brands

16 Dec 08

Naseem Javed, widely recognized as global authority on global corporate nomenclature, image and cyber-branding, author of Naming for Power. Naseem is on global name identity projects and lecturing at various conferences on these ICANN issues.
Naseem Javed

Put People Power Into Action To Improve The NHS, Say Phil Hope And Ara Darzi

05 Dec 08

Patients are being urged to put people power into action from today by rating the service they receive in hospitals using a new tool on the NHS website.
Editor

Big Pharma squares up to changes

03 Dec 08

Paul Hartigan reports from the Financial Times Pharmaceutical Conference: London December 2nd and 3rd 2008
Paul Hartigan

Graduates Lack Knowledge and Skills?

28 Nov 08

‘More universities should provide courses that offer hands-on experience to better prepare their students.’ This is the response from the Head of Cranfield Health, Professor Joe Lunec, after a report claimed that those leaving universities lacked the required knowledge and skills to progress in the UK’s pharmaceutical industry.
Naomie Stanford-Jones

Still No Progress: Mixed Sex Wards And Racial Inequalities

28 Nov 08

According to recent information from MIND, the leading mental health charity, Patient research released today by the Healthcare Commission has revealed that a shocking 68% of mental health inpatients are still being housed on mixed sex wards, showing no improvement on last year's figures
Editor

The real reason why GPs are hard to reach...

26 Nov 08

Our eMarketing team at PharmiWeb Solutions often works with pharma brand teams to find new ways to reach healthcare professionals with news of the latest product or initiative. And sometimes, it can be challenging, with all of the pressures and time constraints that the average primary care practice faces.
Editor

Re-emerging infectious diseases

24 Nov 08

We are facing a world where microbes once again have the potential to cause untreatable diseases, due to the resistance to virtually all available drugs. WHO suggests that even if the pharmaceutical industry were to step up the efforts to develop new drugs immediately, some diseases might still not have any effective therapies within the next ten years.
Visiongain

Merck Serono invests €300 million in state of the art biotechnology center

19 Nov 08

It takes courage to invest €300 million in a production site during a time of financial turmoil”,pointed out Karl-Ludwig Kley, Executive Board Chairman of the pharmaceutical company Merck Serono, this week.
Olwen Glynn Owen

The Global Pain Market, 2008-2023

17 Nov 08

The global pain market generated total sales of $34bn in 2007 – but what will the figures be in the next 5 and 10 years? This report tells you. The pain market has marked strengths and advantages, but is also limited by problems and concerns.
Suvitha Damodaran - Visiongain - Ltd

Combating counterfeit drugs

14 Nov 08

White paper from CERAM highlights novel techniques to expose fake medicines and unlicensed manufacturing processes
Mandy Rymill - CERAM

Gaps In Skills Supply Places UK Biomedical Competitiveness At A Tipping Point

14 Nov 08

The UK’s success as a global centre of biomedical excellence is under threat in the long-term. A new report by the Association of the British Pharmaceutical Industry (ABPI) has highlighted serious concerns about the supply of skills that support the research and development of new medicines.
Editor

The Global Anti-Addiction Market, 2008-2023

14 Nov 08

The global addiction market is significantly undervalued. The world’s population has a large unmet need for addiction therapy drugs. Are you ready for the opportunities this presents?
Suvitha Damodaran - Visiongain Ltd

World Gastrointestinal Disorders

10 Nov 08

The gastrointestinal (GI) disorders market has been one of the largest and most profitable therapeutic areas in the world pharmaceutical industry. With a reported $49.9bn in revenues in 2007, the GI disorders market competes consistently with cardiovascular diseases and oncology for the top 3 therapeutic areas in terms of market value.
Suvitha Damodaran - Visiongain

Women’s Reproductive Disorders Therapeutics Report, 2008-2018

04 Nov 08

There is great potential for the women’s reproductive disorders therapeutics market – can you maximise your company’s potential in this growing market?
Andres Arias - Visiongain

Uncovering The Silent Suffering Of Millions of Women - dealing with Stress Incontinence

04 Nov 08

NHS Direct estimate that one in five UK women over forty years of age suffer from stress incontinence and, whilst it is often caused by childbirth or menopause, it can affect any women at any age.
Sian Rees

Dyselxia Awareness Week

03 Nov 08

Recent reports state that between four and five percent of the population suffer from Dyslexia. It is estimated that there are about 375,000 pupils in the UK with dyslexia and a total of some two million people who are severely affected. Yet it still can be difficult for parents to find the right help for their children.
Editor

Key Mechanism Behind Cancer Spread Is Explained

31 Oct 08

Scientists have discovered the two key processes that allow cancer cells to change the way they move in order to spread through the body, reports leading scientific journal 'Cell'
Editor

Postmenopausal Osteoporotic Patients Granted Treatment Options by the National Institute for Health and Clinical Excellence (NICE)

31 Oct 08

Procter & Gamble Pharmaceuticals (P&GP) acknowledges the publication of the new Technology Appraisal Guidance (TAG 160, for the primary prevention, and 161 for the secondary prevention, of osteoporotic fragility fractures in post-menopausal women) issued by NICE.
Sebastian Stokes -Red Door Communications

Researchers Find New Chemical Key That Could Unlock Hundreds Of New Antibiotics

31 Oct 08

Chemistry researchers at The University of Warwick and the John Innes Centre, have found a novel signalling molecule that could be a key that will open up hundreds of new antibiotics unlocking them from the DNA of the Streptomyces family of bacteria.
Editor

Bayer optimistic about future business trend

30 Oct 08

Following a strong performance in the third quarter, the Bayer Group confirms its targets for 2008. “Despite the difficult environment we expect in the fourth quarter, we are confirming our guidance for 2008 as a whole,”
Editor

Credit crunch threatens new medicines

30 Oct 08

The global financial crisis could seriously delay the discovery and production of many new life-saving medicines, warns a major international conference.
Editor

SIGN IN

Not got a Detail-Direct.com username and password?

Register Here.

Forgot Password?